TARSUS PHARMACEUTICALS
Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.
TARSUS PHARMACEUTICALS
Industry:
Biopharma Biotechnology Life Science
Founded:
2017-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.tarsusrx.com
Total Employee:
101+
Status:
Active
Contact:
(949) 409-9820
Total Funding:
585.6 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Global Site Tag
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Current Advisors List
Board_member
2020-01-01
Current Employees Featured
Aziz Mottiwala Chief Commercial Officer @ Tarsus Pharmaceuticals
Chief Commercial Officer
2020-08-01
Sesha Neervannan Chief Operating Officer @ Tarsus Pharmaceuticals
Chief Operating Officer
2020-01-01
Mark Packer Medical Monitor @ Tarsus Pharmaceuticals
Medical Monitor
2018-11-01
Bobak Azamian President and CEO @ Tarsus Pharmaceuticals
President and CEO
2016-12-01
Jeffrey Farrow Chief Financial Officer and Chief Strategy Officer @ Tarsus Pharmaceuticals
Chief Financial Officer and Chief Strategy Officer
2023-04-01
Founder
Stock Details
Investors List
BioPharma Credit
BioPharma Credit investment in Post-IPO Debt - Tarsus Pharmaceuticals
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Tarsus Pharmaceuticals
Armentum Partners
Armentum Partners investment in Post-IPO Debt - Tarsus Pharmaceuticals
Aperture Venture Partners
Aperture Venture Partners investment in Series B - Tarsus Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series B - Tarsus Pharmaceuticals
Visionary Venture Fund
Visionary Venture Fund investment in Series B - Tarsus Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Tarsus Pharmaceuticals
Flying L Partners
Flying L Partners investment in Series B - Tarsus Pharmaceuticals
Horowitz Group
Horowitz Group investment in Series B - Tarsus Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.tarsusrx.com Semrush global rank: 1.42 M Semrush visits lastest month: 18.04 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tarsus Pharmaceuticals"
Our Leadership - Tarsus
Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science Our Values We …See details»
Tarsus Pharmaceuticals, Inc. - Facebook
Being #GPTWcertified is based on our ability to offer positive outcomes for all teammates in our organization. This …See details»
Tarsus Pharmaceuticals, Inc. | LinkedIn
This morning, the Tarsus Pharmaceuticals, Inc. team gathered (very early!) to share positive Q4 and full-year 2024 financial results. By any standard, 2024 was a remarkable year, as we exceeded ...See details»
Tarsus Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email info@tarsusrx.com Phone Number (949) 409-9820 Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and …See details»
Tarsus Pharmaceuticals - VentureRadar
"Tarsus is a privately held, clinical-stage biopharmaceutical company headquartered in Irvine, California. Tarsus was founded in 2017 to bring innovative therapies to a range of diseases in …See details»
Our Responsibility - Tarsus
Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science Our Values We live our values of commitment, …See details»
Tarsus Pharmaceuticals - Overview, News & Similar companies
May 8, 2024 Tarsus Pharmaceuticals contact info: Phone number: (949) 418-1801 Website: www.tarsusrx.com What does Tarsus Pharmaceuticals do? Founded in 2017, Tarsus …See details»
Tarsus Pharmaceuticals Company Profile | Management and
SQL International Organization for Standardization . CSS World Wide Web Consortium . PHP PHP . Business Intelligence (3 Technologies) Tableau Tableau . Power BI Microsoft . ...See details»
Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial ...
Feb 25, 2025 DNakasone@tarsusrx.com. TARSUS PHARMACEUTICALS, INC. STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (In thousands, except share and per share …See details»
Tarsus Pharmaceuticals - Craft
Oct 29, 2024 Tarsus Pharmaceuticals has 4 employees across 2 locations and $182.95 m in annual revenue in FY 2024. See insights on Tarsus Pharmaceuticals including office locations, …See details»
Tarsus - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 20, 2025 Tarsus - Provider of propriety drugs for treating blepharitis disease. Acquired by Portage Biotech. Raised a total funding of $60M over 1 round from 7 investors. Tarsus has 3 …See details»
Tarsus Pharmaceuticals, Inc. Company Overview, Contact Details ...
Apr 19, 2024 Tarsusrx received financing of $200M in committed capital on Apr 23rd '24. IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) - Tarsus Pharmaceuticals, Inc. …See details»
Tarsus Pharmaceuticals, Inc. (Tarsus Pharmaceuticals, Inc.) - 药物管 …
· ir.tarsusrx.com Tarsus Announces Pricing of Upsized $125.0 Million Public Offering IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) …See details»
Tarsus to Participate in Upcoming Investor Conference
IRVINE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the Barclays 27 …See details»
Our Story - Tarsus
Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science Our Values We …See details»
Careers - Tarsus
Interested in a career at Tarsus? Wellness We offer a comprehensive health and wellness program. All full-time employees and dependents are eligible for medical and dental coverage …See details»
Financials - Tarsus Pharmaceuticals
Mar 20, 2025 Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science …See details»
Our Values - Tarsus
Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science Our Values We …See details»
Tarsus to Participate in Upcoming Investor Conferences
Jan 30, 2025 AKemp@tarsusrx.com. Investor Contact: David Nakasone Head of Investor Relations (949) 620-3223 DNakasone@tarsusrx.com. Toolkit. Print Page; Email Alerts; RSS …See details»
Contact - Tarsus
Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science Our Values We …See details»